Jubilant ingrevia
#jublingrea
Investment of 900cr in 3yrs
Everything from int accruals👌
Splty chem-550cr
Nutrition n health-100cr
Lifescience chem-250cr
Fy22 capex-350cr
Rev potential-900cr @ peak capacity
Diketene-Oct commissioning
CDMO-Apr 2022
Vitamin B3+acetic anhydride

More from Shreenidhi P
#MASTEK
Adding 40+ customers every quarter from an year
650+ active clients
Met 150+ customers/partners virtually in last 40days
Focus to accelerate US growth-have strategy in place
960cr cash on books
Looking for organic+inorganic growth
#CNBCTV18Exclusive | Catch @_anujsinghal, @_soniashenoy & @SurabhiUpadhyay in conversation with @HiralChandrana who was appointed as global CEO of #Mastek last month. He says that a big part of their strategy is to grow in the US. @Reematendulkar pic.twitter.com/nRnfGoGHTp
— CNBC-TV18 (@CNBCTV18News) August 18, 2021
Investor ppt
Splty side:3yr target
Masterbatches-10% rev,20% RoCE
Textile chem-10% rev,25% RoCE
FMCG-Fabricizer launched
30% RoE,22% RoCE-fy21
1% shift in splty adds 5cr EBITDA
Target-62% to 80%
Net d/e 0.5x
D/EBITDA 1x
Petcare-plans 2 demerge in2 seperate entity https://t.co/Iq4VT6tG50

Cosmo films#cosmofilms
— Shreenidhi P (@nid_rockz) August 4, 2021
Probably the best results of the day
Glimpse of last 5qtr
Rev,EBITDA,pbt n PAT growth every qtr
Highest OPM 19%
Q1 EBITDA 132cr n PBT 116cr
Last 5yrs
OPM 7% to 17%\U0001f44c
80% pf-speciality-fy23
Superb debt management
Liberal dividend n buyback
Solid OCF\U0001f44c pic.twitter.com/6ulhmHZf24
More from Jubliantingrevia
Any dip till 740 seems a buying opportunity.
Post Q2 it may give decent up move.
#INVESTING https://t.co/gyyuivs0tT

Ideally this should cross four digit in mid term if they maintain similar growth
— JAKERA CHOUDHURY (@Jakerachoudhury) July 22, 2021
Happy that you are making profit in this. Kudos#jubilant ingrevia https://t.co/le7f6bSjuz
Its an extremely informative AR with broad industry & segment wise overview. MUST READ
Lot of moving parts but looks very optimistic & strong growth outlook.
https://t.co/MxuTZDUfFT

https://t.co/ejcXEAQTHH
#JubilantIngrevia Planned Capex of Rs. 900 Cr. in next 3 yrs.
— Mouzam (@mmali09) March 30, 2021
Entry into Diketene derivatives -game changer.
- Import substitution opp. (40% is imported)
- used in Pharma & Agro Chem
- currently at 50% discount to competitor in India
- one of the leading Int. supplier Exit https://t.co/etPtndC1xN pic.twitter.com/WRQUFXHAtR
https://t.co/7YanRjNE8i
#JubilantIngrevia
— Mouzam (@mmali09) June 24, 2021
\U0001f44cAcquisition of 385,100 equity shares worth Rs 21.36 Cr by the promoter group.
Promoter buying is a Big Positive\U0001f3af
Shows that he is confident about its prospects and believes that investing in the company is better than putting money somewhere else.\U0001f4aa\U0001f4c8 https://t.co/vNYcSr3RgV pic.twitter.com/0WnXGN0UYZ
https://t.co/IW0GRBXi7h
#JUBLINGREA
— Mouzam (@mmali09) July 20, 2021
Super Result\U0001f680QoQ/YoY
Despite covid issues
YoY
Rev 1145Cr vs 737cr (+55%)
EBTDA 25% vs 17%
PAT 168cr vs 53cr (+220%)
EPS 10.6 vs 3.3
\U0001f525All 3 engines
\U0001f9eaInteresting Key CAPEX:
- Dietene on schedule
- CDMO GMP - new
- 2 Multipurpose Spl. Chemical plants new https://t.co/vNYcSr3RgV pic.twitter.com/0rcmB1YMfM
https://t.co/GqcV0GbaLD
Bio-Acetaldehyde - Bio based \U0001f9ec, World\u2019s largest manufacturer from \U0001f1ee\U0001f1f3
— Punit (@punitbansal14) July 28, 2021
Image 1: Benefit in carbon footprint as compared to the conventional petroleum route
Image 2: Bio-Acetaldehyde business overview pic.twitter.com/7M2Eqz5maS